Andon Health Co., Ltd. (SHE:002432)
China flag China · Delayed Price · Currency is CNY
59.20
-2.20 (-3.58%)
Sep 14, 2026, 3:04 PM CST

Andon Health Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,1321,3662,5923,23126,3152,397
Revenue Growth
-43.60%-47.32%-19.77%-87.72%997.80%19.36%
Gross Profit
698.35842.211,8071,95620,7861,512
Operating Income
-268.04-324.28677.15752.6618,500919.31
Net Income
4,4172,2671,6691,25216,030908.64
Earnings Per Share
10.395.213.782.7734.302.00
EPS Growth
129.87%37.73%36.73%-91.93%1615.80%257.03%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23
Special Equipment Manufacturing Industry
890.221,1582,4393,09924.43
Internet Medical Products and Services
166.31121.9876.1637.2117.88
New Retail Business
67.5175.4762.9521.6832.27
Unallocated Other Income
7.549.8513.8560.2748.81
Total
1,1321,3662,5923,23126,315

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
9,26711,57413,63611,38411,7601,343
Total Debt
8,2935,6823,3601,578317.75379.84
Net Cash (Debt)
974.185,89210,2769,80611,443963.56
Net Cash Growth
-90.22%-42.66%4.79%-14.30%1087.52%15.94%
Net Cash Per Share
2.2913.5523.3021.6824.482.12

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-296.77-166.8986.751,77018,222293.11
Capital Expenditures
-290.62-264.33-73.92-212.65-211.9-70.45
Free Cash Flow
-587.4-431.13912.831,55718,010222.67
Free Cash Flow Growth
---41.39%-91.35%7988.15%-45.41%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
61.71%61.67%69.72%60.54%78.99%63.09%
Operating Margin
-23.69%-23.75%26.12%23.29%70.30%38.35%
Pretax Margin
447.94%185.07%81.28%48.91%69.38%41.70%
Profit Margin
390.32%165.99%64.38%38.74%60.92%37.91%
FCF Margin
-51.91%-31.57%35.22%48.20%68.44%9.29%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
1.6501.6500.2000.3002.5000.700
Dividend Per Share Growth
725.00%725.00%-33.33%-88.00%257.14%1066.67%
Dividend Yield
2.43%4.21%0.50%0.82%5.39%1.58%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
5.917.4211.2814.071.4525.45
Forward PE
-41.1741.1741.8623.66165.57
P/FCF Ratio
--20.6111.301.30103.86
PS Ratio
22.7712.317.265.450.899.65